General Information of the Compound
Compound ID
CP0412285
Compound Name
6-[4-[(4-fluorophenyl)methyl]-1,4-diazepan-1-yl]pyridine-3-carboxamide
    Show/Hide
Structure
Formula
C18H21FN4O
Molecular Weight
328.391
Canonical SMILES
NC(=O)c1ccc(nc1)N1CCCN(Cc2ccc(F)cc2)CC1
    Show/Hide
InChI
InChI=1S/C18H21FN4O/c19-16-5-2-14(3-6-16)13-22-8-1-9-23(11-10-22)17-7-4-15(12-21-17)18(20)24/h2-7,12H,1,8-11,13H2,(H2,20,24)
    Show/Hide
InChIKey
COUMQDLXZDVPQA-UHFFFAOYSA-N
Physicochemical Property
logP
2.0319
Rotatable Bonds
4
Heavy Atom Count
24
Polar Areas
62.46
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
24

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 53498895
ChEMBL ID
CHEMBL4162636
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01515, Mu-type opioid receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 5700 nM
   TI
   LI
   LO
   TS